OrbusNeich Medical Group Holdings Limited (HKG:6929)
Hong Kong
· Delayed Price · Currency is HKD 3.740
-0.080 (-2.09%)
May 9, 2025, 3:52 PM HKT
HKG:6929 Revenue
In the year 2024, OrbusNeich Medical Group Holdings had annual revenue of $164.10M USD with 6.65% growth. OrbusNeich Medical Group Holdings had revenue of $85.19M in the half year ending December 31, 2024, with 25.32% growth.
Revenue
$164.10M
Revenue Growth
+6.65%
P/S Ratio
2.42
Revenue / Employee
$123.29K
Employees
1,331
Market Cap
3.08B HKD
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Innovent Biologics | 10.03B |
| Alibaba Health Information Technology | 31.39B |
| Akeso | 2.26B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |